WARNING: This product is for research use only, not for human or veterinary use.
MedKoo CAT#: 315229
Description: Lacosamide, also known as ADD 243037 and SPM 927, is a medication developed by UCB for the adjunctive treatment of partial-onset seizures and diabetic neuropathic pain marketed under the trade name Vimpat. Lacosamide is discontinued (DEA controlled substance).
MedKoo Cat#: 315229
Chemical Formula: C13H18N2O3
Exact Mass: 250.13174
Molecular Weight: 250.2
Elemental Analysis: C, 62.38; H, 7.25; N, 11.19; O, 19.18
Lacosamide is discontinued (DEA controlled substance).
Synonym: Vimpat; erlosamide; ADD 243037; SPM 927; ADD243037; SPM927; ADD-243037; SPM-927.
IUPAC/Chemical Name: (R)-2-acetamido-N-benzyl-3-methoxypropionamide.
InChi Key: VPPJLAIAVCUEMN-GFCCVEGCSA-N
InChi Code: InChI=1S/C13H18N2O3/c1-10(16)15-12(9-18-2)13(17)14-8-11-6-4-3-5-7-11/h3-7,12H,8-9H2,1-2H3,(H,14,17)(H,15,16)/t12-/m1/s1
SMILES Code: O=C(NCC1=CC=CC=C1)[C@H](NC(C)=O)COC
The following data is based on the product molecular weight 250.2 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|1 mM||1.15 mL||5.76 mL||11.51 mL|
|5 mM||0.23 mL||1.15 mL||2.3 mL|
|10 mM||0.12 mL||0.58 mL||1.15 mL|
|50 mM||0.02 mL||0.12 mL||0.23 mL|
1: Hawkes MA, FernÃ¡ndez SuÃ¡rez M, Ugarnes G, D'Giano C. Single-dose oral lacosamide in refractory simple partial status epilepticus: case report and review. Clin Neuropharmacol. 2013 Jul-Aug;36(4):138-40. doi: 10.1097/WNF.0b013e31829b21ba. Review. PubMed PMID: 23860347.